UBS vs HSBC: Earnings Preview as Q4 Results Could Shift European Bank Sentiment
Key Takeaways
-
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY.
-
UBS has beat EPS estimates in the last four quarters by an average of 53%, driven by wealth management inflows and cost savings from Credit Suisse integration.
-
HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
-
Both banks target mid-teens RoTE, with UBS advancing Credit Suisse integration, and HSBC focusing on Asia wealth expansion and cost discipline.
-
UBS emphasizes Swiss precision in wealth and investment banking, while HSBC leverages global scale, especially in Hong Kong and Asia.
-
Investor focus: UBS on integration milestones, HSBC on NII trajectory amid evolving interest rates.
Earnings Context and Why It Matters
UBS’s Q4 report closes a transformative year post-Credit Suisse acquisition, with investors monitoring progress on $13 billion in gross cost savings and non-core asset wind-downs. Despite a revenue dip from elevated prior-year levels, EPS growth is expected, supported by strong wealth inflows and a rebound in investment banking.
HSBC’s Q4 report highlights a different strategy: a global universal bank with a strong Asian focus. Comparing UBS and HSBC underscores diverging paths in European banking—UBS’s wealth-centric Swiss model versus HSBC’s diversified, Asia-driven approach. Both face geopolitical and interest rate pressures, but UBS’s integration execution and HSBC’s NII expansion showcase sector resilience, providing investors insight into European banking stability amid global volatility.
UBS: Earnings in Focus
-
Consensus EPS: $0.25–$0.67 (TipRanks median $0.54) vs. $0.23 last year.
-
Revenue: ~$11.62 billion, down YoY.
-
Key metrics:
-
Global Wealth Management net new assets (Q3: $38B quarterly)
-
Cumulative cost savings: $9.1B toward $13B target
-
CET1 ratio: ~14%
-
Non-Core/Legacy RWA reduction: Target < $8B by 2025-end
-
Investment banking revenues may benefit from solid Q4 deal flow. Historically, UBS has beat estimates by 53% on average, with stock reactions mixed (e.g., -2% post-Q3). Management guidance emphasizes completion of 2026 integration, supporting a ~15% RoCET1 target.
HSBC: Context and Earnings Relevance
-
Q4 consensus EPS: ~$1.57 vs. $1.45 prior.
-
Q3 highlights: Revenue $17.9B (+3% YoY), pre-tax profit $7.3B despite $1.4B legal provisions, NII +15% to $8.8B, and YTD RoTE 17.6% ex-notables.
-
Strategy emphasizes four core businesses (Hong Kong, UK, CIB, Wealth/Premier), mid-single-digit cost growth, and Hang Seng privatization.
-
HSBC’s emerging market exposure contrasts with UBS’s premium Swiss wealth focus. Both prioritize capital returns through dividends and buybacks.
Head-to-Head Earnings and Market Comparison
-
Scale and focus: HSBC ~$63B trailing revenue vs. UBS ~$39B, but UBS delivers higher margins in wealth management (Q3 NNA $92B YTD) vs. HSBC’s volume-driven growth.
-
Earnings quality: UBS average EPS surprise 53%, HSBC consistently strong ex-notables.
-
Growth drivers: UBS’s Credit Suisse synergies (70% of cost saves achieved); HSBC’s Asia pivot (wealth fees double-digit medium-term growth).
-
Risks: UBS faces legacy litigation and integration challenges; HSBC contends with property exposure (Hang Seng NPLs).
-
Valuation and sentiment: UBS trades at a premium, reflecting transformation progress, while HSBC remains a steady execution play amid interest rate sensitivity.
Tickeron AI Perspective
Tickeron AI Verdict
Tickeron’s AI models currently favor UBS, citing:
-
Superior earnings surprise history
-
Accelerating cost efficiencies
-
Positioned growth in high-margin wealth and investment banking
HSBC offers scale and NII resilience, but UBS’s integration execution and RoCET1 trajectory give it a probabilistic edge for outperformance, assuming no major shocks.
Disclaimers and Limitations
UBS sees its Stochastic Oscillator ascends from oversold territory
On July 30, 2026, the Stochastic Oscillator for UBS moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 54 instances where the indicator left the oversold zone. In of the 54 cases the stock moved higher in the following days. This puts the odds of a move higher at over .
Technical Analysis (Indicators)
Bullish Trend Analysis
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where UBS advanced for three days, in of 345 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 322 cases where UBS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
Bearish Trend Analysis
The 10-day RSI Indicator for UBS moved out of overbought territory on July 16, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 45 similar instances where the indicator moved out of overbought territory. In of the 45 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Momentum Indicator moved below the 0 level on July 28, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on UBS as a result. In of 76 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for UBS turned negative on July 20, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 41 similar instances when the indicator turned negative. In of the 41 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where UBS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
UBS broke above its upper Bollinger Band on July 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 20, placing this stock better than average.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. UBS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.939) is normal, around the industry mean (1.957). UBS's P/E Ratio (33.327) is considerably higher than the industry average of (16.446). Projected Growth (PEG Ratio) (0.947) is also within normal values, averaging (1.670). Dividend Yield (0.021) settles around the average of (0.025) among similar stocks. UBS's P/S Ratio (8.361) is very high in comparison to the industry average of (4.362).
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a major bank
Industry MajorBanks
Advertisement